Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.58

+1.8%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Galirayo who wrote (791)	2/11/2005 2:48:07 PM
From: Jibacoa	Read Replies (2) of 3722

ELAB Is moving up for second day on a roll.<g> It is up a modest 5.81% with volume now more than 635K still below yesterday's 741,565 ELAB reportedly has around $2.40 in cash.share, no significant LTD and is Cash Flow & FCF + (About 100.82M and 87.83M respectively.) The stock is trading today above its Feb. Hs and needs to close above its Jan.11 H of 27.38 before it can test its major resistance at the 28.33 level. On a close above that it seems it could get to test its mid-Jul. H at 34.60<g> It announced yesterday that it started shipping Itraconazole 100mg capsules, the generic equivalent to Sporanox capsules. And as the first to file an ANDA it is entitled to 180 days of "exclusivity".(But Janssen is challenging the District Court decision enabling ELAB to market Itraconazole in the US Court of Appeals for the Federal Circuit.<g>) ELAB has had 4Qs of sequentially increasing revenues and earnings (For the 9Ms ended 9/30/04,revenues increased 37% and earnings 75%) bigcharts.marketwatch.com The PSML data on ELAB at present: P=27.04 S=26.09 M=25.78 L=25.83 and SAR=25.40 RSI=64 and rising.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next